BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33818835)

  • 1. Bone marrow metastasis/carcinomatosis in head and neck squamous cell carcinoma.
    Lk Wong B; Wei Chern Gan R; Adabavazeh B; Jose J
    J Oral Pathol Med; 2021 Nov; 50(10):955-961. PubMed ID: 33818835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival outcomes for head and neck cancer patients with N3 cervical nodal metastases.
    Virk JS; Ingle M; Podesta CM; Gujral DM; Awad Z
    Clin Otolaryngol; 2020 May; 45(3):342-349. PubMed ID: 31869000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.
    Descamps G; Karaca Y; Lechien JR; Kindt N; Decaestecker C; Remmelink M; Larsimont D; Andry G; Hassid S; Rodriguez A; Khalife M; Journe F; Saussez S
    J Cancer Res Clin Oncol; 2016 Oct; 142(10):2185-96. PubMed ID: 27370781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-Met expression is a marker of poor prognosis in patients with locally advanced head and neck squamous cell carcinoma treated with chemoradiation.
    Baschnagel AM; Williams L; Hanna A; Chen PY; Krauss DJ; Pruetz BL; Akervall J; Wilson GD
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):701-7. PubMed ID: 24521684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.
    Iyer NG; Tan DS; Tan VK; Wang W; Hwang J; Tan NC; Sivanandan R; Tan HK; Lim WT; Ang MK; Wee J; Soo KC; Tan EH
    Cancer; 2015 May; 121(10):1599-607. PubMed ID: 25639864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rare case of peritoneal metastases from oropharyngeal squamous cell carcinoma in a young male after completion of chemoradiotherapy.
    Aggarwal A; Jindal G; Gupta S; Ruchandani M
    J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S954-S957. PubMed ID: 38384089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck - clinical results from the cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer".
    Maihoefer C; Schüttrumpf L; Macht C; Pflugradt U; Hess J; Schneider L; Woischke C; Walch A; Baumeister P; Kirchner T; Zitzelsberger H; Belka C; Ganswindt U
    Radiat Oncol; 2018 Jul; 13(1):123. PubMed ID: 29970111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curative-Intent Aggressive Treatment Improves Survival in Elderly Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma and High Comorbidity Index.
    Chen JH; Yen YC; Yang HC; Liu SH; Yuan SP; Wu LL; Lee FP; Lin KC; Lai MT; Wu CC; Chen TM; Chang CL; Chow JM; Ding YF; Wu SY
    Medicine (Baltimore); 2016 Apr; 95(14):e3268. PubMed ID: 27057882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of p16 expression, nodal status, and smoking on oncologic outcomes of patients with head and neck unknown primary squamous cell carcinoma.
    Dixon PR; Au M; Hosni A; Perez-Ordonez B; Weinreb I; Xu W; Song Y; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
    Head Neck; 2016 Sep; 38(9):1347-53. PubMed ID: 27002481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review and individual patient data analysis of pediatric head and neck squamous cell carcinoma: An analysis of 217 cases.
    Bhanu Prasad V; Mallick S; Upadhyay AD; Rath GK
    Int J Pediatr Otorhinolaryngol; 2017 Jan; 92():75-81. PubMed ID: 28012539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of disseminated carcinomatosis of the bone marrow originating from gastric cancer 3 years after intraperitoneal chemotherapy against peritoneal carcinomatosis.
    Okuno T; Yamaguchi H; Kitayama J; Ishigami H; Nishikawa T; Tanaka J; Tanaka T; Kiyomatsu T; Hata K; Nozawa H; Kawai K; Kazama S; Ishihara S; Sunami E; Watanabe T
    World J Surg Oncol; 2016 Apr; 14():107. PubMed ID: 27080037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Locally advanced head and neck cancer treated with accelerated radiotherapy, the hypoxic modifier nimorazole and weekly cisplatin. Results from the DAHANCA 18 phase II study.
    Bentzen J; Toustrup K; Eriksen JG; Primdahl H; Andersen LJ; Overgaard J
    Acta Oncol; 2015 Jul; 54(7):1001-7. PubMed ID: 25629651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes after primary chemoradiotherapy for N3 (>6 cm) head and neck squamous cell carcinoma after an FDG-PET--guided neck management policy.
    Adams G; Porceddu SV; Pryor DI; Panizza B; Foote M; Rowan A; Burmeister B
    Head Neck; 2014 Aug; 36(8):1200-6. PubMed ID: 23893554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of squamous cell carcinoma of external auditory canal: A tertiary cancer centre experience.
    Gandhi AK; Roy S; Biswas A; Raza MW; Saxena T; Bhasker S; Sharma A; Thakar A; Mohanti BK
    Auris Nasus Larynx; 2016 Feb; 43(1):45-9. PubMed ID: 26165629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Head and neck squamous cell carcinoma: Ambiguous human papillomavirus status, elevated p16, and deleted retinoblastoma 1.
    Beck TN; Smith CH; Flieder DB; Galloway TJ; Ridge JA; Golemis EA; Mehra R
    Head Neck; 2017 Mar; 39(3):E34-E39. PubMed ID: 27859938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definitive chemoradiotherapy in patients with squamous cell cancers of the head and neck - results from an unselected cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer".
    Schüttrumpf L; Marschner S; Scheu K; Hess J; Rietzler S; Walch A; Baumeister P; Kirchner T; Ganswindt U; Zitzelsberger H; Belka C; Maihoefer C
    Radiat Oncol; 2020 Jan; 15(1):7. PubMed ID: 31906998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of induction chemotherapy for N3 head and neck squamous cell carcinoma.
    Nishikawa D; Hanai N; Ozawa T; Hirakawa H; Suzuki H; Nakashima T; Hasegawa Y
    Auris Nasus Larynx; 2015 Apr; 42(2):150-5. PubMed ID: 25498333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of level V metastasis in head and neck squamous cell carcinoma.
    Kainuma K; Yano T; Kitoh R; Naito T; Usami S
    Acta Otolaryngol; 2013 Feb; 133(2):218-24. PubMed ID: 23145939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility and tolerance of sequential chemoradiotherapy in squamous cell carcinoma of the head and neck.
    Loo SW; Geropantas K; Tasigiannopoulos Z; Martin C; Roques TW
    Eur J Cancer Care (Engl); 2013 Jan; 22(1):32-40. PubMed ID: 22519981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival patterns in squamous cell carcinoma of the head and neck: pain as an independent prognostic factor for survival.
    Reyes-Gibby CC; Anderson KO; Merriman KW; Todd KH; Shete SS; Hanna EY
    J Pain; 2014 Oct; 15(10):1015-22. PubMed ID: 25043982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.